189760-91-6

Basic information

• Product Name: Oxazolidine, 3-[(2R)-4-cyano-2-ethyl-1-oxobutyl]-2-oxo-4-(phenylmethyl)-, (4S)-
• CAS NO: 189760-91-6
• Molecular Formula: C17H20N2O3
• Molecular Weight: 300.357
• Mol File: 189760-91-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Oxazolidine, 3-[(2R)-4-cyano-2-ethyl-1-oxobutyl]-2-oxo-4-(phenylmethyl)-, (4S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Oxazolidine, 3-[(2R)-4-cyano-2-ethyl-1-oxobutyl]-2-oxo-4-(phenylmethyl)-, (4S)-(189760-91-6)
• EPA Substance Registry System: Oxazolidine, 3-[(2R)-4-cyano-2-ethyl-1-oxobutyl]-2-oxo-4-(phenylmethyl)-, (4S)-(189760-91-6)

Safety Data

• Hazardous Substances Data: 189760-91-6(Hazardous Substances Data)

Upstream product

• 111292-87-6 (S)-4-benzyl-3-butyryloxazolidin-2-one 
• 107-13-1 acrylonitrile 

Downstream Products

• 189760-86-9 (2S,7S,8R,9S,12R)-4-Benzenesulfonyl-7,9-bis-(tert-butyl-dimethyl-silanyloxy)-12-(tert-butyl-dimethyl-silanyloxymethyl)-2-((4S,6R)-2,2-di-tert-butyl-6-methyl-[1,3,2]dioxasilinan-4-yl)-8-methyl-tetradecan-5-ol 
• 189760-94-9 (2S,7S,8R,9S,12R)-4-Benzenesulfonyl-7,9-bis-(tert-butyl-dimethyl-silanyloxy)-12-(tert-butyl-dimethyl-silanyloxymethyl)-2-((4S,6R)-2,2-di-tert-butyl-6-methyl-[1,3,2]dioxasilinan-4-yl)-8-methyl-tetradecan-5-one 
• 90719-32-7 4-benzyl-2-oxazolidinone 
• 189760-92-7 (4R)-4-(hydroxymethyl)pentanenitrile 

Relevant articles and documents

Total synthesis of rutamycin B, a macrolide antibiotic from Streptomyces aureofaciens

Rutamycin B (2) was synthesized from three principal subunits, spiroketal 75, keto aldehyde 83, and aldehyde 108. First, triol 62 was assembled by Julia coupling of sulfone 56 with aldehyde 58 followed by an acid-catalyzed spiroketalization. The three hydroxyl functions of 62 were successfully differentiated, leading to phosphonate 75. The latter was condensed in a Wadsworth-Emmons reaction with 83, prepared in six steps from (R)-aldehyde 76, to give 92. Coupling of the titanium enolate of 92 with 108 afforded Felkin product 109 with high stereoselectivity in a process that is critically dependent on the presence of the p-methoxybenzyl ether in the aldehyde. Transformation of 109 via aldehyde 116 to vinylboronate 122 was followed by macrocyclization under Suzuki conditions to yield 123. Exhaustive desilylation of the latter yielded rutamycin B.